| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |